What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak.
Saved in:
| Title: | What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak. |
|---|---|
| Authors: | Mehta M; Department of Pharmacy, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York, United States of America., Purpura LJ; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America.; ICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America., McConville TH; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Neidell MJ; Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, New York, United States of America., Anderson MR; Division of Pulmonary Critical Care, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Bernstein EJ; Division of Rheumatology, Department of Medicine, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York, United States of America., Dietz DE; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Laracy J; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Gunaratne SH; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Miller EH; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Cheng J; Department of Pharmacy, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York, United States of America., Zucker J; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Shah SS; Division of Infectious Diseases, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, United States of America., Chaudhuri S; Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Gordillo CA; Blood and Marrow Transplantation Program, Columbia University Irving Medical Center, New York, New York, United States of America., Patel SR; Division of Pulmonary Critical Care, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Guo TW; Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, United States of America., Karaaslan LE; Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, United States of America., Reshef R; Blood and Marrow Transplantation Program, Columbia University Irving Medical Center, New York, New York, United States of America., Miko BA; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Bathon JM; Division of Rheumatology, Department of Medicine, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, New York, United States of America., Pereira MR; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Uhlemann AC; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Yin MT; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America., Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, United States of America. |
| Source: | PloS one [PLoS One] 2021 Apr 08; Vol. 16 (4), pp. e0249349. Date of Electronic Publication: 2021 Apr 08 (Print Publication: 2021). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0249349 |
